Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study

Gabrielle, Pierre‐Henry; Delyfer, Marie-Noëlle; Glacet–Bernard, A.; Conart, Jean Baptiste; Uzzan, J.; Kodjikian, Laurent; Arndt, Carl; Tadayoni, Ramin; Simonyi, Ágnes; Garcher, Catherine P. Creuzot

doi:10.1016/j.ophtha.2023.04.014

Cited by 7 publications

(3 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies that were small in scale reported initial improvement in VA, but many patients experienced significant complications after the surgery, including retinal detachment, cataract progression, recurrent bleeding, and development of subretinal fibrosis [28–32]. While no consensus exists on the superiority of vitrectomy on SRH management, a recent 2023 study compared PPV with tPA to in-office pneumatic displacement with tPA and showed that PPV was not superior nor added benefits for SRH secondary to nAMD at 3 months after adjustment of SRH size [8]. Patients with SRH smaller than 2 DD were excluded.…”

Section: Surgical Approaches For Srh Management In Amdmentioning

confidence: 99%

“…Of all the patients, 64% had SRH diameter between 2 and 5 DD (small/medium-sized) and 29% had SRH diameter higher than 5 DD (large-sized). Both treatment strategies lead to a clinical improvement of VA without safety concerns for SRH over 6 months [8].…”

Section: Surgical Approaches For Srh Management In Amdmentioning

confidence: 99%

“…SRH is an acute and rare sight-threatening complication characterized by an accumulation of blood under the retina arising from the choroidal or retinal circulation [6, 7]. SRH may portend a poor prognosis with most patients experiencing severe vision loss, often worse than 20/200 [8]. There are many factors that affect the prognosis of SRH such as hemorrhage size, location, time to treatment, and potential involvement of other segments.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Current Management of Subretinal Hemorrhage in Neovascular Age-Related Macular Degeneration

Oncel,

Mishra

et al. 2023

Ophthalmologica

View full text Add to dashboard Cite

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss among individuals aged 65 years and older in the United States. For individuals diagnosed with age-related macular degeneration (AMD), approximately 12% experience varying levels of subretinal hemorrhage (SRH), which can be further classified by size into small, medium, and massive measured in disc diameters. SRH are an acute and rare sight-threatening complication characterized by an accumulation of blood under the retina arising from the choroidal or retinal circulation. Released iron toxins, reduced nutrient supply, fibrin meshwork contraction, and outer retinal shear forces created by SRH contribute to visual loss, macular scarring, and photoreceptor damage. SRH treatment strategies aim to displace hemorrhage from the foveal region and prevent further bleeding. Although there are no standardized treatment protocols for SRH, several surgical and non-surgical therapeutical approaches may be employed. The most common surgical approaches that have been utilized are pars plana vitrectomy (PPV) combined with multiple maneuvers such as the removal of choroidal neovascularization (CNV) lesions, macular translocation, retinal pigment epithelium (RPE) patch repair, SRH drainage, intravitreal injection of recombinant-tissue plasminogen activator (tPA), expansile gas and air displacement, and anti-vascular endothelial growth factor (anti-VEGF) injections. Non-surgical therapeutical approaches include intravitreal anti-VEGF monotherapy, intravitreal t-PA administration without PPV, and photodynamic therapy (PDT). This review article aims to explore the current treatment strategies and supporting literature regarding both surgical and non-surgical, of SRH in patients with AMD. Moreover, this article also aims to highlight the distinct treatment modalities corresponding to different sizes of SRH.

show abstract

Section: Surgical Approaches For Srh Management In Amdmentioning

confidence: 99%

Section: Surgical Approaches For Srh Management In Amdmentioning

confidence: 99%